Non-muscle-invasive bladder cancer (NMIBC) has a high risk of recurrence and progression among patients without adequate Bacillus Calmette-Guérin.
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results